Investors

Investors2018-11-11T00:20:17+00:00

Company Founded

Series A Fundraising

POC Animal

Patents Filed

Series B Fundraising

Founded January

Private investors
Primarily European
Previous Raptor* investors

POC in dogs
Highly translatable to humans
Additional studies underway

2 patents pending

2017

2018

Rapid Corporate Execution on Critical Path Activities

  • CMC
  • Phase 2
*Raptor Pharmaceuticals, Inc.